4DMedical Limited Share Price
Stocks
4DX
AU0000095416
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
10:41:23 19/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.260 AUD | +5.12% |
|
-2.16% | -42.49% |
| 02/11 | 4DMedical Tells ASX Increase in Short Interest Likely Behind Share Price Drop | MT |
| 28/10 | 4DMedical Limited - Shareholder/Analyst Call |
| Market Cap | 129.48Cr 87Cr 79Cr 73Cr 66Cr 124.57Cr 8.12TCr 885.18Cr 349.9Cr 4.38TCr 326.08Cr 319.25Cr 14TCr | P/E 2027 * |
-32.9x | P/E 2028 * | -67.9x |
|---|---|---|---|---|---|
| Enterprise Value | 105.82Cr 71Cr 65Cr 60Cr 54Cr 101.81Cr 6.64TCr 723.42Cr 285.96Cr 3.58TCr 266.49Cr 260.91Cr 11TCr | EV / Sales 2027 * |
53.7x | EV / Sales 2028 * | 21.2x |
| Free-Float |
84.09% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| 4DX | Delayed | |
| FDMDF | Delayed | ||
| MQ7 | Real-time | ||
| MQ7 | Delayed | ||
| MQ7 | Real-time |
Last Transcript: 4DMedical Limited
| 1 day | +5.12% | ||
| 1 week | -2.16% | ||
| Current month | -7.38% | ||
| 1 month | -41.60% | ||
| 3 months | -40.37% | ||
| 6 months | -38.08% | ||
| Current year | -42.49% |
| 1 week | 2.02 | 2.33 | |
| 1 month | 2.02 | 3.92 | |
| Current year | 2.02 | 7.55 | |
| 1 year | 1.4 | 7.55 | |
| 3 years | 0.22 | 7.55 | |
| 5 years | 0.22 | 7.55 | |
| 10 years | 0.22 | 7.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 01/12/2012 |
Chris Cox
DFI | Director of Finance/CFO | - | 28/10/2026 |
Greg Mogel
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
BRD | Director/Board Member | - | 01/12/2012 |
John Livingston
BRD | Director/Board Member | - | 01/10/2017 |
Julian Sutton
CHM | Chairman | - | 28/10/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/06/26 | Buy | Chief Financial Officer | 13,054 | 0.0022% | ||
| 04/03/26 | Exercice | Director | 2,13,464 | 0.0373% | ||
| 04/03/26 | Exercice | Director | 2,13,464 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.12% | -2.16% | +57.49% | +218.31% | 87Cr | ||
| +0.87% | -3.48% | +20.26% | +48.52% | 26TCr | ||
| +1.24% | -2.86% | +1.36% | +10.01% | 16TCr | ||
| -2.23% | -6.36% | -23.01% | +37.89% | 15TCr | ||
| +1.42% | -3.30% | -56.02% | -19.69% | 6.33TCr | ||
| -0.19% | -0.55% | +25.21% | +57.29% | 6.05TCr | ||
| +0.26% | +0.53% | +6.43% | -11.94% | 5.35TCr | ||
| +2.97% | +0.21% | +23.28% | +56.72% | 5TCr | ||
| -3.89% | -9.05% | +1.27% | +57.02% | 4.49TCr | ||
| +3.63% | -1.02% | +23.76% | +77.98% | 4.58TCr | ||
| Average | +0.92% | -3.98% | +8.00% | +53.21% | 9TCr | |
| Weighted average by Cap. | +0.38% | -3.96% | +3.11% | +34.38% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.97Cr 1.32Cr 1.21Cr 1.11Cr 1.01Cr 1.89Cr 123.51Cr 13Cr 5.32Cr 67Cr 4.96Cr 4.85Cr 210.51Cr | 5.11Cr 3.43Cr 3.13Cr 2.89Cr 2.61Cr 4.92Cr 320.56Cr 35Cr 14Cr 173.03Cr 13Cr 13Cr 546.37Cr |
| Net income | -4.08Cr -2.74Cr -2.5Cr -2.31Cr -2.08Cr -3.93Cr -255.93Cr -28Cr -11Cr -138.14Cr -10Cr -10Cr -436.21Cr | -1.93Cr -1.3Cr -1.18Cr -1.09Cr -98.78L -1.86Cr -121.3Cr -13Cr -5.23Cr -65Cr -4.87Cr -4.77Cr -206.74Cr |
| Net Debt | -24Cr -16Cr -14Cr -13Cr -12Cr -23Cr -1.48TCr -161.75Cr -64Cr -801.12Cr -60Cr -58Cr -2.53TCr | -21Cr -14Cr -13Cr -12Cr -11Cr -20Cr -1.33TCr -144.97Cr -57Cr -718.01Cr -53Cr -52Cr -2.27TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | A$2.260 | +5.12% | 36,82,341 |
| 18/26/18 | A$2.150 | +0.94% | 31,98,173 |
| 17/26/17 | A$2.130 | -2.74% | 66,51,734 |
| 16/26/16 | A$2.190 | -4.78% | 34,82,634 |
| 13/26/13 | A$2.300 | -0.43% | 34,76,890 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4DX Stock
Select your edition
All financial news and data tailored to specific country editions
















